PREDICTIVE POWER OF OXIDATIVE STRESS BIOMARKERS IN RECURRENCE AND SURVIVAL IN ADVANCED CERVICAL CANCER
Keywords:biomarkers, cervical cancer, cancer recurrence, oxidative stress, antioxidative enzymes, 8-hydroxy-2-deoxyguanosine
The aim of our study was to measure the levels of 8-hydroxy-2-deoxyguanosine, malondialdehyde, and antioxidant enzymes in patients with locally advanced cervical cancer prior to treatment to determine how these evaluated biomarkers are associated with cervical cancer recurrence and to estimate their potential in further research and clinical use. Materials and Methods. The study included 45 female patients with newly diagnosed advanced cervical cancer who underwent concomitant chemoradiotherapy. The blood and urine samples were collected prior to treatment, between December 2013 and April 2016, and subsequent laboratory analysis was performed. After the medium follow-up of 29 months, the patients were divided into 3 groups according to the time of disease recurrence. A statistical analysis was performed in order to evaluate the relationship between the previously measured biomarkers and recurrence. Results. Taken individually, the parameters of oxidative stress did not reveal significant differences between the three groups in our study. Nevertheless, the catalase and glutathione S-transferase activities were the best predictors of the recurrence. Based on the activities of these two oxidative enzymes, it was possible to separate the group of patients without recurrence after follow-up from the other two groups of patients with recurrent disease. Conclusions. The parameters of oxidative stress have a certain predictive value on the outcome of patients with advanced cervical cancer after concomitant chemo-radiotherapy.
Slimen IB, Najar T, Ghram A, et al. Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperth. 2014;30(7):513-523. doi: 10.3109/02656736.2014.971446
Nimse SB, Pal D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv. 2015;5(35):27986- 28006. doi:10.1039/C4RA13315C3
Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.
Physiol Rev. 2014;94(3):909-950. doi: 10.1152/physrev.00026.2013
World Cancer Report 2014. IARC Publications. Available from: https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014
Chan CK, Aimagambetova G, Ukybassova T, et al. Human papillomavirus infection and cervical cancer: epi- demiology, screening, and vaccination—review of current perspectives. J Oncol. 2019; 2019: 3257939. doi: 10.1155/2019/3257939
Chetty R. 70 years of the JCP-highly cited papers: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2017;70(12):997. doi: 10.1136/jclinpath-2017-2048677
Senapati R, Senapati NN, Dwibedi B. Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer. 2016;11:59. doi: 10.1186/s13027-016-0107-48
Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 2016;7(6):e2253. doi: 10.1038/cddis.2016.105
De Marco F. Oxidative stress and HPV carcinogenesis. Viruses. 2013;5(2):708-731. doi: 10.3390/v5020708
Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55-74. doi: 10.1016/j.ejmech.2015.04.040
Mila-Kierzenkowska C, Kedziora-Kornatowska K, Wozniak A, et al. The effect of brachytherapy on antioxidant status and lipid peroxidation in patients with cancer of the uterine cervix. Cell Mol Biol Lett. 2004;9(3):511–518.
Kolanjiappan K, Manoharan S, Kayalvizhi M. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta. 2002;326(1–2):143-149. doi: 10.1016/s0009- 8981(02)00300-5
Srivastava S, Natu SM, Gupta A, et al. Lipid peroxidation and antioxidants in different stages of cervical cancer: Prognostic significance. Indian J Cancer. 2009;46(4):297. doi: 10.4103/0019-509X.55549
Looi ML, Mohd Dali AZH, Md Ali SA, et al. Oxidative damage and antioxidant status in patients with cervi- cal intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer Prev. 2008;17(6):555-560. doi: 10.1097/ CEJ.0b013e328305a10b
Sharma A, Rajappa M, Satyam A, et al. Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response. Mol Cell Biochem. 2010;341(1–2):65-72. doi: 10.1007/s11010-010-0437-2
Bhuvarahamurthy V, Balasubramanian N, Govindasamy S. Effect of radiotherapy and chemoradiotherapy on cir- culating antioxidant system of human uterine cervical carcinoma. Mol Cell Biochem. 1979;158(1):17-23. doi: 10.1007/BF00225878
Mukundan H, Bahadur AK, Kumar A, et al. Glutathione level and its relation to radiation therapy in patients with cancer of uterine cervix. IJEB. 1999;37(9):859-864.
Jelić M, Mandić A, Kladar N, et al. Lipid peroxidation, antioxidative defense and level of 8-hydroxy-2-deoxy- guanosine in cervical cancer patients. J Med Biochem. 2018;37(3):336-345. doi: 10.1515/jomb-2017-0053
Zahra K, Patel S, Dey T, Pandey U, Mishra SP. A study of oxidative stress in cervical cancer- an institutional study.
Biochem Biophys Rep. 2020;25:100881. doi: 10.1016/j.bbrep.2020.100881
Al Mamun N, Al Mamun NA, Quyyum SA, et al. Comparison of different blood biomarkers of cervical cancer patients with control subjects. J Bangladesh Acad Sci. 2022;46(1):117-125. doi:10.3329/jbas.v46i1.60443
Hristozov D, Gadjeva V, Vlaykova T, et al. Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem. 2001;109(4):331-336. doi: 10.1076/apab.109.4.331.4248
Rajendran P, Nandakumar N, Rengarajan T, et al. Antioxidants and human diseases. Clin Chim Acta. 2014;436:332- 347. doi: 10.1016/j.cca.2014.06.004
Hercbergs A, Brok-Simoni F, Holtzman F, et al. Erythrocyte glutathione and tumour response to chemotherapy.
Lancet. 1992;339(8801):1074-1076. doi: 10.1016/0140-6736(92)90664-o
Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2002;22:7369. doi: 10.1038/sj.onc.1206940
Tormos C, Javier Chaves F, Garcia MJ, et al. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Cancer Lett. 2004;208(1):103-113. doi: 10.1016/j.canlet.2003.11.007
Poprac P, Jomova K, Simunkova M, et al. Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci. 2017;38(7):592-607.
Nakano T, Oka K, Taniguchi N. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res. 1996;56(12):2771-2775.
Bernardetta P, Giovanni P, Renata C, et al. Increased growth capacity of cervical-carcinoma cells over-expressing manganous superoxide dismutase. Int J Cancer. 1999;82(1):145-150. doi: https://doi.org/10.1002/(SICI)1097-215(19990702)82:1<145::AID-IJC24>3.0.CO;2-B
Che M, Wang R, Li X, et al. Expanding roles of superoxide dismutases in cell regulation and cancer. Drug Discov Today. 2016;21(1):143-149. doi: 10.1016/j.drudis.2015.10.001
Wang Y, Branicky R, Noë A, et al. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol. 2018;217(6):1915-1928. doi: 10.1083/jcb.201708007
Prabhu K, Gummadi MR, Anjali R. Can antioxidants predispose to cancer recurrence? Asian Pacific J Trop Med. 2010; 3(6):494-495. doi: https://doi.org/10.1016/S1995-7645(10)60119-8
Submitted: February 13, 2022.
How to Cite
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.